We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidelines for the effective operation of breast pathology services
This guidance outlines the scope and standards for medical physics services for the NHS breast screening programme.
This leaflet is for women who have had only partial or incomplete mammography during NHS breast screening.
This guidance is for breast screening services to help them advise women seeking breast screening who are not registered with a GP practice.
NHS breast screening programme procedures to collect, monitor and report repeat mammographic examinations.
Guidance on establishing consent for bowel cancer screening, and how to manage people who wish to temporarily opt out, or be ceased (removed), from screening.
The quality assurance process within the AAA screening programme includes monitoring mortality rates in patients with abdominal aortic aneurysms.
This document provides guidance on the vascular nurse specialist role for local AAA screening services in England.
Role, responsibilities and training for clinical skills trainers and internal quality assurance lead in the NHS abdominal aortic aneurysm screening (AAA) programme.
A payment approach that has the potential to drive greater collaboration between all services within an urgent and emergency care network.
An approach to payment for providers of IAPT services that links payment to patient outcomes as well as the provider’s levels of activity.
The Infectious Diseases in Pregnancy Screening Programme's Integrated Screening Outcomes Surveillance Service (ISOSS) report on pregnancies to women with HIV.
Information and advice for parents of babies with suspected medium-chain acyl-CoA dehydrogenase deficiency (MCADD) following a baby’s screening test result.
An overview of the sickle cell and thalassaemia (SCT) screening end-to-end pathway.
Sickle cell and thalassaemia high/low prevalence laboratory return 2025 to 2026
A 5-year deal setting out how community pharmacy will support delivery of the NHS Long Term Plan.
This guidance sets out the data which diabetic eye screening (DES) services must submit nationally and the related dataset that provider IT systems require.
Guidance for when a person with diabetes chooses to be screened by a different diabetic eye screening (DES) service from the one their GP is linked to.
This document is national guidance for local diabetic eye screening providers when managing patients who drive to their appointment.
This document explains how all diabetic eye screening (DES) graders must participate in the national test and training (TAT) grading system.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).